• This topic is empty.
Viewing 0 reply threads
  • Author
    • #15058

      Delpharm will manufacture MS1819 using enteric (slower dissolving) capsules for a Phase 2b trial in CF patients with exocrine pancreatic insufficiency. Read more here.

      What do you think of this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account

Verify you are not a robot